Hassannia, H.; Amiri, M.M.; Ghaedi, M.; Sharifian, R.-A.; Golsaz-Shirazi, F.; Jeddi-Tehrani, M.; Shokri, F.
Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model. Cancers 2022, 14, 5827.
https://doi.org/10.3390/cancers14235827
AMA Style
Hassannia H, Amiri MM, Ghaedi M, Sharifian R-A, Golsaz-Shirazi F, Jeddi-Tehrani M, Shokri F.
Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model. Cancers. 2022; 14(23):5827.
https://doi.org/10.3390/cancers14235827
Chicago/Turabian Style
Hassannia, Hadi, Mohammad Mehdi Amiri, Mojgan Ghaedi, Ramezan-Ali Sharifian, Forough Golsaz-Shirazi, Mahmood Jeddi-Tehrani, and Fazel Shokri.
2022. "Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model" Cancers 14, no. 23: 5827.
https://doi.org/10.3390/cancers14235827
APA Style
Hassannia, H., Amiri, M. M., Ghaedi, M., Sharifian, R.-A., Golsaz-Shirazi, F., Jeddi-Tehrani, M., & Shokri, F.
(2022). Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model. Cancers, 14(23), 5827.
https://doi.org/10.3390/cancers14235827